| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |